AML Research and Therapy in 2025

In order to receive the certificate of participation, you are required to fill out the registration form.

Registration link

Thursday, February 20th, 2025

01:30 PM (GMT)

05:00 PM (Tehran Time)

Join Zoom Meeting:

https://howardcollege-edu.zoom.us/j/99249872538

Meeting ID: 992 4987 2538

Passcode: TUMS-2025

Dr. Hagop Kantarjian

Chair, Leukemia Department, MD Anderson Cancer Center, USA

Dr. Hagop Kantarjian is Chair of the Leukemia Department at MD Anderson Cancer Center in Houston, Texas. He is a fellow in health care policies at the Baker Institute at Rice University. His research focuses on translational-clinical developmental therapeutics in leukemia. Over the past 4 decades, he has made numerous contributions that improved patient prognosis and survival across the leukemia entities, with over 2,400 peer reviewed publications. In addition to his 40+ year career as a leukemia researcher, he has been involved in health care policies, and published extensively on issues related to the Affordable Care Act (ObamaCare), health care as a human right, cancer drug prices, 340B, HPV vaccines, and others.

Dr. Kamran Alimoghadam

Professor, Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, Tehran University of Medical Sciences, Iran

Dr. Marjan Yaghmaie

Professor, Research Institute for Oncology, Hematology and Cell Therapy, Shariati Hospital, Head of Leading House for Iran-North America Academic Partnerships, Tehran University of Medical Sciences, Iran

(Facilitator)